20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3133 | YM-90709 | YM90709,YM 90709 | IL Receptor , Interleukin |
YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor. | |||
T3185 | R112 | (E)-Elafibranor | Syk |
R112 ((E)-Elafibranor) is an ATP-competitive inhibitor of Syk kinase. | |||
T80585 | Anti-Mouse GM-CSF Antibody (MP1-22E9) | c-Fms | |
Anti-Mouse GM-CSF Antibody is a rat-derived IgG2a isotype inhibitor that targets mouse granulocyte-macrophage colony-stimulating factor (GM-CSF). | |||
T0089 | Cetirizine dihydrochloride | P071,UCB P071,Cetirizine DiHCl | Histamine Receptor |
Cetirizine dihydrochloride (UCB P071) is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventiona... | |||
T76690 | Mavrilimumab | CAM 3001 | Virus Protease , CSF-1R |
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that has an affinity for the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor and blocks downstream intracellul... | |||
T77125 | Otilimab | GSK 3196165,MOR103 | CSF-1R |
Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking... | |||
T9840 | Ataquimas | Immunology/Inflammation related | |
Ataquimast inhibits IL-5 secretion along with that of TNF-a, IL-4 and GM-CSF from human cells. | |||
T81135 | Sodium caseinates | ||
Sodium caseinate, the predominant milk protein salt of casein, promotes the proliferation and activation of granulocytes and elevates serum concentrations of cytokines GM-CSF and G-CSF, thereby inducing murine granulopoi... | |||
T29797 | AKB-6899 | AKB6899 | VEGFR , HIF/HIF Prolyl-Hydroxylase , HIF |
AKB-6899 is an inhibitor of prolyl hydroxylase domain 3 (PHD3) and increases the soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages. AKB-6899 leads to stabilization of HIF-2α which in... | |||
TP2008L | Lyn peptide inhibitor acetate | Lyn peptide inhibitor acetate(222018-18-0 free base) | IL Receptor |
Lyn peptide inhibitor acetate is a potent and cell-permeable inhibitor of Lyn-coupled IL-5 receptor signaling pathway, while keeping other signals intact. Lyn peptide inhibitor blocks Lyn activation and inhibits the bind... | |||
T76820 | Namilumab | ||
Namilumab (AMG203), a human IgG1 monoclonal antibody, exhibits high affinity binding to the GM-CSF ligand, effectively neutralizing GM-CSF. It has potential application in researching rheumatoid arthritis [1]. | |||
T79149 | Magmas-IN-1 | Others | |
Magmas-IN-1 (compound 9), a small molecule Magmas inhibitor (SMMI), targets the mitochondria-associated granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling molecule and GM-CSF inducible gene in myeloid ce... | |||
T77025 | Gimsilumab | ||
Gimsilumab (MORAb-022), a humanized anti-GM-CSF monoclonal antibody, shows promise in the research of COVID-19 and rheumatoid arthritis (RA) [1] [2]. | |||
T77116 | Plonmarlimab | ||
Plonmarlimab (TJ003234), an anti-GM-CSF monoclonal antibody, is utilized in researching rheumatoid arthritis and COVID-19 [1] [2]. | |||
T76751 | Lenzilumab | ||
Lenzilumab (KB 003) is a humanized monoclonal antibody designed to target CSF2/GM-CSF, with applications in COVID-19 and studies on chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) [1] [... | |||
T73659 | HLF1-11 | ||
HLF1-11, derived from human lactoferrin, serves as a broad-spectrum antimicrobial agent. It not only inhibits human MPO (myeloperoxidase) activity but also influences GM-CSF (granulocyte-macrophage colony-stimulating fac... | |||
T74971 | Diamino lipid DAL4 | ||
Diamino lipid DAL4 is novel lipid nanoparticles (LNPs) encapsulated with mRNAs encoding cytokines including IL-12 , IL-27 and GM-CSF . Diamino lipid DAL4 delivers mRNA to tumor cells to exert anti-tumor activity [1] . | |||
T82938 | ATUX-1215 | ||
ATUX-1215, a protein phosphatase 2A (PP2A) activator, diminishes the phosphorylation of ERK, p38, JNK, and Akt, as well as decreases the secretion of IL-12p70, GM-CSF, and IL1α in BLM-treated animals, potentially deceler... | |||
TP2008 | Lyn peptide inhibitor | ||
Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinoph... | |||
T80959 | Trabikibart | CSL311 | |
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, specifically binds to the cytokine-binding epitope of the human βc receptor with picomolar affinity. It potently inhibits the collective impact of IL-... |